Learn more

G NTS VIRUSOLOGII I BIOT

Overview
  • Total Patents
    37
About

G NTS VIRUSOLOGII I BIOT has a total of 37 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Russian Federation. Its main competitors in its focus markets environmental technology and pharmaceuticals are KUMABE KIYOSHI, GUANGDONG ZIJIN ZHENGTIAN PHARMACEUTICAL CO LTD and TIANJIN JINHAIMA AQUACULTURE CO LTD.

Patent filings in countries

World map showing G NTS VIRUSOLOGII I BIOTs patent filings in countries
# Country Total Patents
#1 Russian Federation 37

Patent filings per year

Chart showing G NTS VIRUSOLOGII I BIOTs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Masycheva V I 6
#2 Il Ichev A A 6
#3 Sandakhchiev L S 5
#4 Loktev V B 4
#5 Kolokol Tsova T D 4
#6 Nechaeva E A 4
#7 Varaksin N A 3
#8 Lebedev L R 3
#9 Tjunnikov G I 3
#10 Rjabicheva T G 3

Latest patents

Publication Filing date Title
RU2216590C1 Recombinant attenuated strain of bacterium salmonella typhimurium t10/pkhbc as producer of hepatitis b virus core antigen
RU2217501C2 Set of oligonucleotides-primers for identification of rubella virus
RU2214416C2 Rgd-containing peptides
RU2211040C2 Method for preparative isolation of high density lipoprotein fraction from plasma or serum blood
RU2210361C2 Method for obtaining microcapsulated form of measles vaccine for peroral intake
RU2209830C2 Set of oligonucleotides-primers for identification of hemorrhagic fever crimean-congo virus rna
RU2200543C2 Method of concentrated acetate solution "gemovekt" preparing for hemodialysis
RU2197736C1 Reagent for immunoenzyme analysis and method of immunoenzyme testing of specific antibody in opisthorchiasis caused by hepatic trematode opisthorchis felineus
RU2194755C2 Recombinant plasmid dna pad5-f carrying of adenovirus type 5 genome fragment with deletion in gene e1b-55k and strain of mutant adenovirus ade 12 exhibiting selective antitumor activity
RU2189231C1 Emulsion preparation for prophylaxis of respiratory viral infections
RU2194075C2 Recombinant plasmid dna ptbi-hbsag comprising chimeric gene tbi-hbsag under control of smallpox vaccine promoter p7,5k and strain of recombinant smallpox vaccine inducing immune response against hiv and human hepatitis b in animal body
RU2190417C2 Preparation for decreasing toxicity of chemically synthesized antitubercular medicinal preparations
RU2182830C1 Tablet form of recombinant human erythropoietin
RU2189223C2 Agent for deep cutaneous defects healing
RU2193567C2 Protected calcitonine peptides
RU2190018C2 Molecular vector for delivering genes to target cells
RU2190017C2 Recombinant plasmid dna p7shshis for production of dimeric single-stranded antibody against tick-borne encephalitis virus and strain of escherichia coli as producer of dimeric form of single-stranded antibody against tick-borne encephalitis virus
RU2189575C2 Sampler for biogenic particles in space
RU2217162C2 Vaccine against viral infections
RU2189393C2 Recombinant plasmid dna pu11hhv6 providing expression of gene u11 fragment of human herpes virus of 6 type encoding immunodominant moiety of protein tegument p100 in cells of bacterium escherichia coli